RIVA-RANITIDINE 300
LABORATOIRE RIVA INC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is RIVA-RANITIDINE 300 discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that RIVA-RANITIDINE 300 300MG has been permanently discontinued (last updated September 14, 2019). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
ZANTAC TAB 300MG
GLAXO CANADA INC
NU-RANIT TAB 300MG
NU-PHARM INC
Other Products
ZANTAC-C CAP 300MG
GLAXO CANADA INC
RATIO-RANITIDINE
RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED
ZANTAC-C CAP 150MG
GLAXO CANADA INC
ZANTAC TAB 150MG
GLAXO CANADA INC
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02247815
Strength
300MG
Dosage Form
TABLET
Route
ORAL
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.